XNAS · Laboratory Analytical Instruments · S&P 500
$12.18
+$0.32 (+2.70%) today
Open $11.86 High $12.32 Low $11.71 Vol 251K Avg $12.16
Find similar stocks by technical condition — S&P 500 universe
| Symbol | Company Name | Exchange | Currency | Category |
|---|---|---|---|---|
| AMS | American Shared Hospital Services | XASE | USD | SERVICES-MEDICAL LABORATORIES |
| SERA | Sera Prognostics, Inc. Class A Common Stock | XNAS | USD | SERVICES-MEDICAL LABORATORIES |
| ADVB | Advanced Biomed Inc. Common Stock | XNAS | USD | SERVICES-MEDICAL LABORATORIES |
| CSTL | Castle Biosciences, Inc. Common Stock | XNAS | USD | SERVICES-MEDICAL LABORATORIES |
| ACON | Aclarion, Inc. Common Stock | XNAS | USD | SERVICES-MEDICAL LABORATORIES |
| XGN | Exagen Inc. Common Stock | XNAS | USD | SERVICES-MEDICAL LABORATORIES |
52-week price range
Price is 88.8% above its 52-week low and 37.4% below its 52-week high. Trading in the lower half of its annual range — closer to the floor than the ceiling.
Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities, including MRI, CT, PET, X-ray, ultrasound, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated by the Outpatient segment, which performs imaging studies and provides radiologists' interpretations of those studies.